News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Arndt Vogel/X
Jun 8, 2025, 16:48

Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a post on X:

“Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable PDAC, published in JCO.
Phs II Trial PANACHE01 FRENCH08 PRODIGE48 study
– mFOLFIRINOX feasible
– supports ongoing trials such as PREOPANC3, Alliance AO21806″

PANACHE01

Title: Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)

Journal: JCO

Authors: Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, Olivier Bouché, Eric Assenat, Guillaume Piessen, Pascal Hammel, Nicolas Regenet, Julien Taieb, Olivier Turrini, Francois Paye, Anthony Turpin, Francois-Regis Souche, Christophe Laurent, Reza Kianmanesh, Pierre Michel, Dewi Vernerey, Jean-Yves Mabrut, Celia Turco, Stephanie Truant, Antonio Sa Cunha

Read the full article.

PANACHE01

More posts featuring Arndt Vogel on OncoDaily.

Anthony Turpin Antonio Sa Cunha Arndt Vogel ASCO Aurelia Meurisse cancer Celia Turco Christophe Laurent Dewi Vernerey Eric Assenat Francois Paye Francois-Regis Souche FRENCH08 Guillaume Piessen Hannover Medical School JCO Jean-Baptiste Bachet Jean-Yves Mabrut Julien Taieb Lilian Schwarz mFOLFIRINOX Nicolas Regenet Olivier Bouché Olivier Turrini OncoDaily Oncology PANACHE01 pancreatic adenocarcinoma Pascal Hammel PDAC Pierre Michel PREOPANC3 PRODIGE48 Reza Kianmanesh Stephanie Truant
Special Coverage
Career
Jul 19, 2025, 17:37
Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute
Blog
Jul 19, 2025, 17:27
Thor Halfdanarson: What's on My NET PubMed Radar
Science
Jul 19, 2025, 17:26
Myeloma Paper of the Day, July 19th, Suggested by Robert Orlowski
Blog
Jul 19, 2025, 16:59
Walid Kamoun: The Evolution of Survival Rates for Lung Adenocarcinoma Over The Past 20 Years
Blog
Jul 19, 2025, 16:48
Eric Small: My Presidential Theme for 2025-2026
Blog
Jul 19, 2025, 16:41
What Makes the SIOP Congress So Special?
Blog
Jul 19, 2025, 16:35
Alisher Kahharov: An Exceptional Experience Visiting the Private Practice of Benjamin Sarfati
Career
Jul 19, 2025, 16:20
Maria do Céu Diniz Borborema Celebrates Winning the SLAOP Young Oncologist Award
Career
Jul 19, 2025, 16:08
Stephanie Graff is the New Associate Director of Global Oncology and Policy at Legorreta Cancer Center at Brown University
Blog
Jul 19, 2025, 16:06
Behind Every Brain Tumor Warrior is a Caregiver Who Deserves Support - WeTrials
Blog
Jul 19, 2025, 16:04
Jame Abraham Welcomes Andrew Stiff to Cleveland Clinic
Insight
Jul 19, 2025, 15:58
Amol Akhade: The Quiet Death of What Was Once an Intellectual Battleground?